» Articles » PMID: 21505724

Early Intervention of ERK Activation in the Spinal Cord Can Block Initiation of Peripheral Nerve Injury-induced Neuropathic Pain in Rats

Overview
Publisher Science Press
Specialty Physiology
Date 2011 Apr 21
PMID 21505724
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The present study is to investigate whether the extracellular signal-regulated kinase (ERK) and cAMP response element binding protein (CREB) signaling pathway contributes to the initiation of chronic constriction injury (CCI)-induced neuropathic pain in rats. Mechanical allodynia was assessed by measuring the hindpaw withdrawal threshold in response to a calibrated series of von Frey hairs. Thermal hyperalgesia was assessed by measuring the latency of paw withdrawal in response to a radiant heat source. The expressions of phosphor-ERK (pERK) and phosphor-CREB (pCREB) were examined using Western blot analysis and immunohistochemistry. An early robust increase in the expression of pERK on the spinal cords ipsilateral to injury was observed on day 1 after CCI, when the CCI-induced behavioral hypersensitivity had not developed yet. Moreover, the upregulation of pERK expression in ipsilateral spinal cord was associated with the increase in pCREB expression in bilateral spinal cord. Intrathecal administration of mitogen-activated protein kinase kinase (MEK) inhibitor U0126 before CCI can efficiently block and delay the CCI-induced mechanical allodynia and thermal hyperalgesia. These data suggest that activation of ERK and CREB in the spinal cord contributes to the initiation of peripheral nerve injury-induced pain hypersensitivity, and an early intervention strategy should be proposed.

Citing Articles

Astaxanthin has a beneficial influence on pain-related symptoms and opioid-induced hyperalgesia in mice with diabetic neuropathy-evidence from behavioral studies.

Ciapala K, Pawlik K, Ciechanowska A, Makuch W, Mika J Pharmacol Rep. 2024; 76(6):1346-1362.

PMID: 39528765 PMC: 11582234. DOI: 10.1007/s43440-024-00671-9.


Advances in Neuropathic Pain Research: Selected Intracellular Factors as Potential Targets for Multidirectional Analgesics.

Ciapala K, Mika J Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004489 PMC: 10675751. DOI: 10.3390/ph16111624.


Analgesic Effects of Fisetin, Peimine, Astaxanthin, Artemisinin, Bardoxolone Methyl and 740 Y-P and Their Influence on Opioid Analgesia in a Mouse Model of Neuropathic Pain.

Ciapala K, Rojewska E, Pawlik K, Ciechanowska A, Mika J Int J Mol Sci. 2023; 24(10).

PMID: 37240346 PMC: 10219356. DOI: 10.3390/ijms24109000.


Novel Non-Opioid Based Therapeutics for Chronic Neuropathic Pain.

Doyle T, Braden K, Harada C, Mufti F, Schafer R, Salvemini D Mo Med. 2021; 118(4):327-333.

PMID: 34373667 PMC: 8343628.


Characterization of changes of pain behavior and signal transduction system in food-deprived mice.

Jang S, Park S, Jung J, Lee H, Hong J, Lee J Anim Cells Syst (Seoul). 2018; 22(4):227-233.

PMID: 30460102 PMC: 6138332. DOI: 10.1080/19768354.2018.1490348.